KNOTT DAVID M - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
KNOTT DAVID M ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$195,000
-4.9%
42,117
-20.7%
0.11%
-17.8%
Q1 2020$205,000
-6.4%
53,117
-8.9%
0.13%
+44.9%
Q4 2019$219,000
-72.8%
58,317
-61.5%
0.09%
-73.7%
Q3 2019$804,000
-39.0%
151,415
-55.9%
0.34%
-39.2%
Q2 2019$1,318,000
-49.4%
343,347
-32.8%
0.56%
-46.4%
Q1 2019$2,605,000
+121.1%
510,847
-16.7%
1.04%
+87.4%
Q4 2018$1,178,000
-43.7%
613,447
+10.8%
0.55%
-18.4%
Q3 2018$2,092,000
+30.6%
553,475
+7.8%
0.68%
+13.0%
Q2 2018$1,602,000
+37.2%
513,475
+5.1%
0.60%
+24.9%
Q1 2018$1,168,000
-21.4%
488,575
+28.5%
0.48%
-18.6%
Q4 2017$1,486,000
+61.5%
380,110
+4.1%
0.59%
+50.4%
Q3 2017$920,000
-6.3%
365,110
+2.6%
0.39%
-4.1%
Q2 2017$982,000
+77.3%
355,750
+25.1%
0.41%
+53.6%
Q1 2017$554,000284,3500.27%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 252,199$749,0002.35%
MANGROVE PARTNERS IM, LLC 3,031,965$9,005,0001.14%
ARMISTICE CAPITAL, LLC 10,000,000$29,700,0001.08%
GABLES CAPITAL MANAGEMENT INC. 432,864$1,286,0000.83%
Worth Venture Partners, LLC 268,682$798,0000.66%
XTX MARKETS LLC 18,749$56,0000.27%
Capital Impact Advisors, LLC 203,133$603,0000.18%
Wealthspire Advisors, LLC 337,770$1,003,0000.06%
ROYCE & ASSOCIATES LP 1,784,890$5,301,0000.06%
XML Financial, LLC 40,000$119,0000.04%
View complete list of CATALYST PHARMACEUTICALS INC shareholders